BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34442626)

  • 41. Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study.
    Russo E; Bacci G; Chiellini C; Fagorzi C; Niccolai E; Taddei A; Ricci F; Ringressi MN; Borrelli R; Melli F; Miloeva M; Bechi P; Mengoni A; Fani R; Amedei A
    Front Microbiol; 2017; 8():2699. PubMed ID: 29375539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gut microbiota in patients after surgical treatment for colorectal cancer.
    Jin Y; Liu Y; Zhao L; Zhao F; Feng J; Li S; Chen H; Sun J; Zhu B; Geng R; Wei Y
    Environ Microbiol; 2019 Feb; 21(2):772-783. PubMed ID: 30548192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Differences between colorectal cancer patients and healthy people in fecal microbiota and metabolites].
    Wang X; Wang J; Rao B; Deng L; Huang Y; Zeng G; Chen C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1106-10. PubMed ID: 26616803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploring Gut Microenvironment in Colorectal Patient with Dual-Omics Platform: A Comparison with Adenomatous Polyp or Occult Blood.
    Wei PL; Wu MS; Huang CK; Ho YH; Hung CS; Lin YC; Tsao MF; Lin JC
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening.
    Rezasoltani S; Aghdaei HA; Jasemi S; Gazouli M; Dovrolis N; Sadeghi A; Schlüter H; Zali MR; Sechi LA; Feizabadi MM
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal Microbial Dysbiosis in Beagles Naturally Infected with Canine Parvovirus.
    Park JS; Guevarra RB; Kim BR; Lee JH; Lee SH; Cho JH; Kim H; Cho JH; Song M; Lee JH; Isaacson RE; Song KH; Kim HB
    J Microbiol Biotechnol; 2019 Sep; 29(9):1391-1400. PubMed ID: 31434168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobia.
    Fujio-Vejar S; Vasquez Y; Morales P; Magne F; Vera-Wolf P; Ugalde JA; Navarrete P; Gotteland M
    Front Microbiol; 2017; 8():1221. PubMed ID: 28713349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.
    Amitay EL; Krilaviciute A; Brenner H
    Gut Microbes; 2018 Jul; 9(4):293-307. PubMed ID: 29543545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.
    Liu F; Li J; Guan Y; Lou Y; Chen H; Xu M; Deng D; Chen J; Ni B; Zhao L; Li H; Sang H; Cai X
    Int J Biol Sci; 2019; 15(11):2381-2392. PubMed ID: 31595156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal Cancer Patients Have Four Specific Bacterial Species in Oral and Gut Microbiota in Common-A Metagenomic Comparison with Healthy Subjects.
    Uchino Y; Goto Y; Konishi Y; Tanabe K; Toda H; Wada M; Kita Y; Beppu M; Mori S; Hijioka H; Otsuka T; Natsugoe S; Hara E; Sugiura T
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel promising diagnosis model for colorectal advanced adenoma and carcinoma based on the progressive gut microbiota gene biomarkers.
    Xu J; Zheng Z; Yang L; Li R; Ma X; Zhang J; Yin F; Liu L; Xu Q; Shen Q; Shen X; Wu C; Liu J; Qin N; Sheng J; Jin P
    Cell Biosci; 2022 Dec; 12(1):208. PubMed ID: 36572910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential Mucosal Microbiome Profiles across Stages of Human Colorectal Cancer.
    Zhang M; Lv Y; Hou S; Liu Y; Wang Y; Wan X
    Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Gut Microbial Diversity of Newly Diagnosed Diabetics but Not of Prediabetics Is Significantly Different from That of Healthy Nondiabetics.
    Gaike AH; Paul D; Bhute S; Dhotre DP; Pande P; Upadhyaya S; Reddy Y; Sampath R; Ghosh D; Chandraprabha D; Acharya J; Banerjee G; Sinkar VP; Ghaskadbi SS; Shouche YS
    mSystems; 2020 Mar; 5(2):. PubMed ID: 32234773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteroides, butyric acid and t10,c12-CLA changes in colorectal adenomatous polyp patients.
    Chen C; Niu M; Pan J; Du N; Liu S; Li H; He Q; Mao J; Duan Y; Du Y
    Gut Pathog; 2021 Jan; 13(1):1. PubMed ID: 33436066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer.
    Ishaq HM; Mohammad IS; Hussain R; Parveen R; Shirazi JH; Fan Y; Shahzad M; Hayat K; Li H; Ihsan A; Muhammad KS; Usman M; Zhang S; Yuan L; Ullah S; Paiva-Santos AC; Xu J
    J Cancer; 2022; 13(6):2014-2028. PubMed ID: 35399732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
    Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ
    Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
    Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
    World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.